Fundraising FoxLabgeniustx
2 known investors
Find your way into Labgeniustx
Sign up to see every warm intro you have to Labgeniustx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Labgeniustx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LabGenius develops EVA, an automated antibody discovery platform that uses machine learning and automation to identify and co-optimize complex therapeutic antibodies such as multispecifics. Its internal pipeline focuses on selectivity-enhanced antibodies for treating solid tumours.
Investors · 2
__Twitter.png)
M VenturesreportedAmsterdam · $10.8M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Labgeniustx do?
- LabGenius develops EVA, an automated antibody discovery platform that uses machine learning and automation to identify and co-optimize complex therapeutic antibodies such as multispecifics. Its internal pipeline focuses on selectivity-enhanced antibodies for treating solid tumours.
- Who are Labgeniustx's investors?
- Labgeniustx's investors include Gaingels, M Ventures.